Rates of antimicrobial resistance in Latin America (2004-2007) and in vitro activity of the glycylcycline tigecycline and of other antibiotics

Brazilian Journal of Infectious Diseases

Volumn 12, Issue 5, 2008, Pages 405-415

  Rossi, Flávia ^a   Garcia, Patricia ^b   Ronzon, Bernando ^c   Curcio, Daniel ^d   Dowzicky, Michael ^e  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^c HOSPITAL ÁNGELES DEL PEDREGAL   (Mexico)

^d Instituto Sacre Cour   (Argentina)

^e PFIZER INC   (United States)

Author keywords

Antibacterial resistance; Latin America; Surveillance; Tigecycline

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CLAVULANIC ACID; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; LEVOFLOXACIN; LINEZOLID; METICILLIN; MINOCYCLINE; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; TIGECYCLINE; VANCOMYCIN; ANTIINFECTIVE AGENT; CL 331002; DRUG DERIVATIVE; TETRACYCLINE DERIVATIVE;

ACINETOBACTER; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARGENTINA; ARTICLE; BACTERIUM ISOLATE; BRAZIL; CHILE; COLOMBIA; GEOGRAPHIC DISTRIBUTION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; GUATEMALA; HONDURAS; HOSPITAL INFECTION; HUMAN; IN VITRO STUDY; JAMAICA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MEXICO; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PANAMA; PSEUDOMONAS AERUGINOSA; PUERTO RICO; SOUTH AND CENTRAL AMERICA; VENEZUELA; CLINICAL TRIAL; DRUG EFFECT; HEALTH SURVEY; INTERNATIONAL COOPERATION; MICROBIOLOGICAL EXAMINATION; MULTICENTER STUDY;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MICROBIAL; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; INTERNATIONAL COOPERATION; LATIN AMERICA; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; POPULATION SURVEILLANCE; TETRACYCLINES;

EID: 65449155591     PISSN: 14138670     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1413-86702008000500012     Document Type: Article

References (21)

1. Deshpande L.M., Fritsche T.R., Moet G.J., et al. Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program. Diagn Microbiol Infect Dis 2007;58(2):163-70.
2. Falagas M.E., Karveli E.A. The changing global epidemiology of Acinetobacter baumannii infections: a development with major public health implications. Clin Microbiol Infect 2007;13:17-9.
3. Sader H.S., Jones R.N., Gales A.C., et al. SENTRY antimicrobial surveillance program report: Latin America and Brazilian results for 1997 through 2001. Braz J Infect Dis 2004;8:25-79.
4. Andrade S.S., Sader H.S., Jones R.N., et al. Increased resistance to first-line agents among bacterial pathogens isolated from urinary tract infections in Latin America: time for local guidelines? Memórias de Instituto Oswaldo Cruz, Rio de Janeiro 2006:101;741-8.
5. Felmingham D. The need for antimicrobial resistance surveillance. J Antimicrob Chemother 2002;50(suppl. S1):1-7.
6. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, document M7-A6. NCCLS, 2003.
7. Wyeth Pharmaceuticals Inc. Tygacil Product Insert. Philadelphia, PA, USA, 2007. http://www.tygacil.com (last accessed 24 April 2007).
8. th informational supplement, document M100-S16. CLSI, 2006.
9. Mendes C., Marin M.E., Quiñones F., et al. Antibacterial resistance of community-acquired respiratory tract pathogens recovered from patients in Latin America : results from the PROTEKT Surveillance Study (1999-2000). Braz J Infect Dis 2003;7:44-61.
10. Informe Anual de la Red de Monitoreo/Vigilancia de la Resistencia a los Antibióticos, 2003. Organización Panamericana de la Salud, Oficina Regional de la Organización Mundial de la Salud (OPS/DPC/ CD/332/05).
11. Informe Anual de la Red de Monitoreo/Vigilancia de la Resistencia a los Antibióticos, 2004 (Brasilia, Brasil 27 al 29 de julio, 2005). Organización Panamericana de la Salud, Oficina Regional de la Organización Mundial de la Salud (OPS/HDM/CD/A/408/06).
12. Sader H.S., Jones R.N., Gales A.C., et al. SENTRY Antimicrobial Surveillance Program Report: Latin American and Brazilian Results for 1997 through 2001. Braz J Infect Dis 2004;8:25-79.
13. Gales A.C., Andrade S.S., Sader H.S., Jones R.N. Activity of mupirocin and 14 additional antibiotics against staphylococci isolated from Latin American hospitals: report from the SENTRY antimicrobial surveillance program. J Chemother 2004;16:323-8.
14. Sader H.S., Fritsche T.R., Streit J.M., Jones R.N. Daptomycin in vitro activity tested against Gram-positive strains collected from European and Latin American centers in 2003. J Chemother 2005; 17:477-83.
15. Gales A.C., Jones R.N. and Sader H.S. Global assessment of the antimicrobial activity of polymixin B against 54 731 isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance program 2001-2004. Clin Microbiol Infect 2006;12:315-21.
16. Stelling J.M., Travers K., Jones R.N., et al. Integrating Escherichia coli antimicrobial susceptibility data from multiple surveillance programs. Emerg Infect Dis 2005;11:873-82.
17. Rossi F., Baquero F., Hsueh P.-R., et al. In vitro susceptibilities of aerobic and facultative anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends). J Antimicrob Chemother 2006;58:205-10.
18. Krobot K., Yin D., Zhang Q., et al. Effect of inappropriate initial empiric antibiotic therapy on outcome of patients with community-acquired intra-abdominal infections requiring surgery. Eur J Clin Microbiol Infect Dis 2004;23:682-7.
19. Gales A.C., Jones R.N., Andrade S.S., Pereira A.S., Sader H.S. In vitro activity of tigecycline, a new glycylcycline, tested against 1,326 clinical bacterial strains isolated from Latin America. Braz J Infect Dis 2005:9;348-56.
20. Hoban D.J., Bouchillon S.K., Johnson B.M., et al. In vitro activity of tigecycline against 6792 Gram-negative and Gram-positive clinical isolates from the global Tigecycline Evaluation and Surveillance Trial (TEST Program, 2004). Diagn Microbiol Infect Dis 2005:52;215-27.
21. Lincopan N., McCulloch JA, Reinert C., et al. First isolation of metallo-β-lactamase-producing multiresistant Klebsiella pneumoniae from a patient in Brazil. J Clin Microbiol 2005; 43:516-9.